Showing 601 - 620 results of 36,983 for search '(( significant decrease decrease ) OR ( significant ((clinical disease) OR (linear decrease)) ))', query time: 0.50s Refine Results
  1. 601
  2. 602
  3. 603
  4. 604
  5. 605
  6. 606
  7. 607
  8. 608
  9. 609

    S5 Fig - by Katrine Carlsen (5477300)

    Published 2024
    Subjects:
  10. 610
  11. 611
  12. 612
  13. 613
  14. 614
  15. 615
  16. 616
  17. 617

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  18. 618
  19. 619
  20. 620

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”